Gene-expression profiling in vaccine therapy and immunotherapy for cancer
about
Checkpoint Inhibitors and Their Application in Breast CancerImmunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trialsNew approaches to understanding the immune response to vaccination and infectionImmunotherapy in gastric cancerAn immunologic portrait of cancerOvercoming tumor immune evasion with an unique arbovirusIntratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.Immunological network signatures of cancer progression and survivalCancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination.Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome.Study of the integrated immune response induced by an inactivated EV71 vaccineGene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.A genetic inference on cancer immune responsivenessMethods to measure vaccine immunity.Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 PhenotypeHighly multiplexed quantitation of gene expression on single cells.CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.Humoral immune responses to EGFR-derived peptides predict progression-free and overall survival of non-small cell lung cancer patients receiving gefitinib.Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma.Immune biomarkers: how well do they serve prognosis in human cancers?Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy.Harnessing the immune system for the treatment of melanoma: current status and future prospects.Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients' Response to Immunotherapy.Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors.Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein.Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells.Conference Scene: Immunotherapy reaches new milestones in cancer eradication.Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.Pioneering the trail of cancer immunotherapy.Molecular and Genomic Impact of Large and Small Lateral Dimension Graphene Oxide Sheets on Human Immune Cells from Healthy DonorsMelanoma & biomarkers of immunoresponsiveness
P2860
Q26745442-118CD823-DC01-4C02-BA42-87B0FECD8E1CQ26765115-AF2B497B-2248-4A4A-AA63-F416F3DE77BDQ26800283-FADD1916-88E9-4C30-BB7C-8A7BC8A18279Q27010472-C31A7826-4884-43C4-857C-43A06CB3CEE4Q27028000-9E6EFBC8-171C-4F6E-B926-860E7122CD00Q28081774-27493499-C88A-4EC8-B874-249D83A95D38Q30276128-3089B1C0-17B3-4920-8BEB-204DD1B774B1Q33750137-832718A6-8750-471F-8ECF-37110BFA0C8DQ33858844-CB77C722-1789-4437-9C2A-4525F98765F6Q33954123-25843AD8-6283-4788-B8A1-26F1A4E1DBA0Q34372945-052791A3-015A-49ED-A097-DF86159E76CFQ34571186-16C89AD1-0DB3-4A40-984B-EB2F4645D9D1Q35541507-7C7D846C-646F-470E-BBC0-B5CF26754DA4Q36057497-B788B097-B95C-40CF-9A55-02011F21CFF6Q36423975-90402AA6-C957-4A95-8CA2-C1D381668799Q36925103-DD9A5595-B5F4-421C-B5A8-876B398B6216Q37270293-17463165-5B10-42F1-92CA-B09AF32D3978Q37279217-E2A85D17-4A7E-445C-8F0B-8D25EAD5C46BQ37538406-70B2F26A-214B-4564-9AB6-9C6036D25FE4Q38195656-01582577-57B9-4704-AF21-BA04716CC78CQ38262757-3FC1CDEF-DE43-4781-A075-ED42D7FF5CA2Q38284345-6C01305F-797F-4B18-AC50-0F891AE11CA0Q38806243-219BE01F-B447-4D3E-AA9D-2E7B0F47E03CQ38875037-3AFF14D3-749E-4439-8897-A9C376727DF5Q39414681-1AF23A74-6951-45C2-8C17-5B1F90C39043Q41483538-F662F5EC-60D3-419C-968D-A29524C78FF9Q41976096-FAACD8C6-CFFC-48AF-A283-C8C98BB847BAQ42645831-1674B720-029A-4D7E-A537-73FBEC748881Q45336492-FA7036FD-A9D1-4DB5-ACBC-CE92FA6CCF0BQ47101079-B61D73F6-DB63-4CAF-BA74-B576D32341B7Q51160791-E45EFB8C-5541-4C53-B852-826BF6D40FC8Q58234437-69383A71-6C89-41FD-A23C-84E291F82499Q58234468-A32CABE6-4E40-4F60-963C-18F005A4D656
P2860
Gene-expression profiling in vaccine therapy and immunotherapy for cancer
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Gene-expression profiling in vaccine therapy and immunotherapy for cancer
@ast
Gene-expression profiling in vaccine therapy and immunotherapy for cancer
@en
type
label
Gene-expression profiling in vaccine therapy and immunotherapy for cancer
@ast
Gene-expression profiling in vaccine therapy and immunotherapy for cancer
@en
prefLabel
Gene-expression profiling in vaccine therapy and immunotherapy for cancer
@ast
Gene-expression profiling in vaccine therapy and immunotherapy for cancer
@en
P2093
P2860
P356
P1476
Gene-expression profiling in vaccine therapy and immunotherapy for cancer
@en
P2093
Francesco M Marincola
Mario Roberto Sertoli
P2860
P304
P356
10.1586/ERV.10.55
P577
2010-06-01T00:00:00Z